Livia Livinț-Popa

Dr. Livia Livinț-Popa

Department of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania
+1
Departament of Neurosciences, Iuliu Hațieganu University of ...

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Livia Livinț-PopaLivia Livinț-Popa
Livia Livinț-Popa
DCDiana Chira
Diana Chira
SSStefan Strilciuc
Stefan Strilciuc
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Traumatic brain injury (TBI) is a significant public health concern, often leading to long-lasting impairments in cognitive, motor and sensory functions. The rapid development of non-invasive systems has revolutionized the field of TBI rehabilitation by offering modern and effective interventions. This narrative review explores the application of non-invasive technologies, including electroencephalography (EEG), quantitative electroencephalography (qEEG), brain–computer interface (BCI), eye tracking, near-infrared spectroscopy (NIRS), functional near-infrared spectroscopy (fNIRS), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), magnetoencephalography (MEG), and transcranial magnetic stimulation (TMS) in assessing TBI consequences, and repetitive transcranial magnetic stimulation (rTMS), low-level laser therapy (LLLT), neurofeedback, transcranial direct current stimulation (tDCS), transcranial alternative current stimulation (tACS) and virtual reality (VR) as therapeutic approaches for TBI rehabilitation. In pursuit of advancing TBI rehabilitation, this narrative review highlights the promising potential of non-invasive technologies. We emphasize the need for future research and clinical trials to elucidate their mechanisms of action, refine treatment protocols, and ensure their widespread adoption in TBI rehabilitation settings.

30 October 2025 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
CPCristina Pantelemon
Cristina Pantelemon
LCLacramioara Eliza Chiperi
Lacramioara Eliza Chiperi
BIBianca Iftimie
Bianca Iftimie
Livia Livinț-PopaLivia Livinț-Popa
Livia Livinț-Popa
VTValentina Tarau-Sas
Valentina Tarau-Sas
DMDafin Fior Muresanu
Dafin Fior Muresanu
Background/Objectives: Sleep disturbances are among the most prevalent and persistent comorbidities in children and adolescents with autism spectrum disorder (ASD), affecting up to 83% of this population. These disturbances not only impact the quality of life but are increasingly recognized as significant contributors to behavioral dysregulation. Methods: This systematic review synthesizes evidence from 26 studies published between 2010 and 2024, examining the association between sleep problems and behavioral outcomes in individuals with ASD aged 2 to 18 years. Results: The findings reveal consistent associations between sleep-onset insomnia, night walking, bedtime resistance, and various behavioral difficulties, including aggression, hyperactivity, and emotional dysregulation. Internalizing symptoms and exacerbation of core ASD features were also linked to chronic sleep problems. Studies employing objective sleep measures, such as actigraphy and polysomnography, further supported these associations by identifying disruptions in sleep architecture correlated with behavioral severity. While most included studies were of moderate to high methodological quality, the limited number of randomized controlled trials and heterogeneity of sleep and behavior assessment tools highlight the need for standardization. Conclusions: Overall, the review emphasizes the importance of routine sleep evaluation in ASD clinical care and supports targeted sleep interventions as a potential strategy to reduce behavioral problems and improve developmental outcomes.

12 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CPCristina Pantelemon
Cristina Pantelemon
LCLacramioara Eliza Chiperi
Lacramioara Eliza Chiperi
BIBianca Iftimie
Bianca Iftimie
Livia Livinț-PopaLivia Livinț-Popa
Livia Livinț-Popa
ESEmanuel Stefanescu
Emanuel Stefanescu
DMDafin Fior Muresanu
Dafin Fior Muresanu
Background: Early detection of autism spectrum disorder (ASD) is essential, as the first two years of life represent a critical window of neuroplasticity during which timely interventions can improve developmental outcomes. Traditional diagnostic methods, such as ADOS and ADI-R, rely on caregiver reports and structured observations, limiting ecological validity and accessibility. Eye-tracking (ET) offers a non-invasive, scalable approach to assess early atypical gaze patterns. Objectives: This systematic review and meta-analysis synthesized evidence on the diagnostic accuracy of ET for early ASD detection and its potential as an adjunctive screening tool. Methods: A comprehensive search of PubMed, Scopus, Web of Science, Medline, and the Cochrane Library identified studies published between January 2015 and July 2025. Eligible studies evaluated ET in infants and toddlers (≤36 months) for early ASD identification, following PRISMA guidelines. Results: Out of 513 records, 57 studies were included. Most studies reported reduced fixation on social stimuli, atypical gaze following, and preference for geometric over social images in infants later diagnosed with ASD. Pooled effect sizes indicated a moderate-to-large difference between ASD and typically developing groups in social fixation time (Hedges’ g ≈ 0.65, 95% CI: 0.48–0.82, I2 = 58%). Studies integrating machine learning algorithms (n = 14) achieved improved sensitivity (up to 89%) and specificity (up to 86%) compared with conventional gaze metrics. Conclusions: Overall, ET shows strong potential as an early adjunctive screening method for ASD. Nonetheless, methodological heterogeneity and lack of standardized protocols currently limit clinical translation, underscoring the need for multi-center validation and task standardization.

30 August 2024 in Medicine
Verified
Journal Article
Open access
NDNicu Catalin Draghici
Nicu Catalin Draghici
RBRoxana Bolchis
Roxana Bolchis
Livia Livinț-PopaLivia Livinț-Popa
Livia Livinț-Popa
VVVitalie Vacaras
Vitalie Vacaras
SISilvina Iluț
Silvina Iluț
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Lower limb entrapment neuropathies comprise a wide range of disorders, including less common conditions like tarsal tunnel syndrome, Morton neuroma, obturator nerve entrapment syndrome, superior gluteal nerve entrapment, and cluneal nerve entrapment syndrome. Despite being less prevalent, these syndromes are equally significant, presenting with symptoms such as pain, dysesthesia, muscular weakness, and distinct physical signs. Accurate diagnosis of these less common disorders is crucial for successful therapy and patient recovery, as they can sometimes be mistaken for lumbar plexopathies, radiculopathies, or musculotendinous diseases. This narrative review highlights the significance of identifying and diagnosing these particular neuropathies through a comprehensive assessment of the patient’s medical history, detailed physical examination, and the use of electrodiagnostic and/or ultrasound investigations. When the diagnosis is uncertain, advanced imaging techniques like magnetic resonance neurography or magnetic resonance imaging are necessary to confirm the diagnosis. A positive diagnosis ensures prompt and targeted treatments, preventing further nerve impairments and muscle wasting. This article explores the epidemiology, anatomy, pathophysiology, etiology, clinical presentation, and electrodiagnostic interpretation of lower limb entrapment neuropathies, highlighting the importance of precise diagnosis in achieving favorable patient outcomes.

8 October 2025 in Sensors
Verified
Journal Article
Open access
PDF file
DCDiana Chertic
Diana Chertic
VDVictor Dabala
Victor Dabala
Livia Livinț-PopaLivia Livinț-Popa
Livia Livinț-Popa
MBMaria Balea
Maria Balea
NDNicu Catalin Draghici
Nicu Catalin Draghici
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
Chronic pain (CP) represents a multidimensional condition in which cognitive and emotional factors shape the individual experience from perception to action. The purpose of this study was to characterize the functional significance of alterations in neural oscillatory dynamics underlying the transition from resting-state to cognitive load across distinct CP phenotypes. Continuous electroencephalographic data were acquired from patients with headache, migraine, and spine-related pain, as well as healthy controls, during rest and three visual–cognitive–motor (VCM) tasks: reaction time, working memory, and associative learning. First, within CP subgroups, we examined cognitive-load-related changes in oscillatory activity. In migraine patients, alpha/beta power attenuation induced during cognitive processing correlated with higher reported pain intensity. Relative to the spine-related pain group, migraine patients exhibited increased occipital alpha and gamma band activity during working memory and associative learning conditions, as a possible neurophysiological signature of cortical hyperexcitability. By comparing a subset of headache patients to healthy controls, we found elevated resting-state delta and gamma activity in the patient group. Under cognitive load conditions, headache patients showed higher power across delta, theta, beta, and gamma frequency bands. Delta and theta activity elicited during the working memory task correlated negatively with pain intensity. Our results demonstrate that the experience of chronic pain is accompanied by frequency-specific alterations in both resting and cognitive-associated oscillatory dynamics, reflecting impaired visual working-memory processing and top–down modulation of behaviorally relevant stimuli.

28 September 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Dafin Fior MuresanuDafin Fior Muresanu
Dafin Fior Muresanu
OROlivia Verisezan Rosu
Olivia Verisezan Rosu
NJNicoleta Jemna
Nicoleta Jemna
IBIrina Benedek
Irina Benedek
JRJulia Rednic
Julia Rednic
SSStefan Strilciuc
Stefan Strilciuc
Background: Cognitive deficits following ischemic stroke significantly impair quality of life, highlighting the need for effective interventions. This study evaluates the efficacy and safety of extended N-Pep-12 dietary supplementation in enhancing cognitive recovery post-stroke. Methods: In this randomized, open-label, controlled study, 106 patients with supratentorial ischemic stroke were enrolled to receive either 90mg N-Pep-12 or no supplementation daily for 360 days and were followed-up for 360 days. Cognitive function and emotional well-being were assessed using established neuropsychological scales at baseline, 90 days, and 360 days post-stroke. Safety was monitored through adverse events and mortality rates. Results: Significant improvements were observed in the N-Pep-12 group compared to controls, particularly in the Montreal Cognitive Assessment scores at both 90 and 360 days, and in the Digit Symbol Coding scores at 360 days, suggesting enhanced cognitive recovery with extended N-Pep-12 supplementation. A linear regression for a composite outcome analysis at day 360 further confirmed the efficacy of N-Pep-12 in contributing to cognitive improvement. Safety profiles were favorable, with no significant adverse effects attributed to N-Pep-12. Conclusions: Extended dietary supplementation with N-Pep-12 appears to offer a safe and effective approach to support cognitive recovery in ischemic stroke survivors. These findings underscore the potential of the supplement as an add-on intervention for managing post-stroke cognitive impairments.